Monrovia, CA, United States of America

Miles Douglas Kubota

This inventor holds 2 USPTO granted patents. Top assignee: Suvalent Therapeutics, Inc.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Miles Douglas Kubota. Retrieved from https://idiyas.com/inventor/miles-douglas-kubota

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.8

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Miles Kubota: Innovator in Cancer Treatment

Introduction

Miles Kubota is an accomplished inventor based in Monrovia, California. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel compounds.

Latest Patents

Miles Kubota holds a patent for "Sumo inhibitor compounds and uses thereof." This invention relates to compounds and compositions capable of acting as inhibitors of the small ubiquitin-like modifier (SUMO) family of proteins. The compounds and compositions developed by Kubota may be utilized in the treatment of cancer. His patent also discloses methods for inhibiting an E1 enzyme, along with compounds that are effective in this inhibition.

Career Highlights

Miles Kubota is currently associated with Suvalent Therapeutics, Inc., where he continues to advance his research in the field of oncology. His work focuses on developing innovative therapeutic solutions that can improve patient outcomes.

Collaborations

Some of his notable coworkers include Xiaohu Ouyang and Ted Charles Judd, who collaborate with him in his research endeavors.

Conclusion

Miles Kubota's contributions to cancer treatment through his patented innovations highlight his role as a key figure in the field of medical research. His work continues to pave the way for advancements in therapeutic strategies against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…